By the way, this is the mechanism by which I see Invex looking at another indication. Prof. Sinclair - via the University of Birmingham - must have submitted grants to look at the effects of Presendin in stroke and TBI etc. This is the most cost-effective way to boost the research pipeline.
By the way, this is the mechanism by which I see Invex looking...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.21pm 15/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable